首页> 美国卫生研究院文献>Frontiers in Cellular and Infection Microbiology >PvdQ Quorum Quenching Acylase Attenuates Pseudomonas aeruginosa Virulence in a Mouse Model of Pulmonary Infection
【2h】

PvdQ Quorum Quenching Acylase Attenuates Pseudomonas aeruginosa Virulence in a Mouse Model of Pulmonary Infection

机译:PvdQ群体猝灭酰基转移酶减弱了肺部感染小鼠模型中的铜绿假单胞菌的毒力。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Pseudomonas aeruginosa is the predominant pathogen in pulmonary infections associated with cystic fibrosis. Quorum sensing (QS) systems regulate the production of virulence factors and play an important role in the establishment of successful P. aeruginosa infections. Inhibition of the QS system (termed quorum quenching) renders the bacteria avirulent thus serving as an alternative approach in the development of novel antibiotics. Quorum quenching in Gram negative bacteria can be achieved by preventing the accumulation of N-acyl homoserine lactone (AHL) signaling molecule via enzymatic degradation. Previous work by us has shown that PvdQ acylase hydrolyzes AHL signaling molecules irreversibly, thereby inhibiting QS in P. aeruginosa in vitro and in a Caenorhabditis elegans model of P. aeruginosa infection. The aim of the present study is to assess the therapeutic efficacy of intranasally instilled PvdQ acylase in a mouse model of pulmonary P. aeruginosa infection. First, we evaluated the deposition pattern of intranasally administered fluorochrome-tagged PvdQ (PvdQ-VT) in mice at different stages of pulmonary infection by in vivo imaging studies. Following intranasal instillation, PvdQ-VT could be traced in all lung lobes with 42 ± 7.5% of the delivered dose being deposited at 0 h post-bacterial-infection, and 34 ± 5.2% at 72 h post bacterial-infection. We then treated mice with PvdQ during lethal P. aeruginosa pulmonary infection and that resulted in a 5-fold reduction of lung bacterial load and a prolonged survival of the infected animals with the median survival time of 57 hin comparison to 42 h for the PBS-treated group. In a sublethal P. aeruginosa pulmonary infection, PvdQ treatment resulted in less lung inflammation as well as decrease of CXCL2 and TNF-α levels at 24 h post-bacterial-infection by 15 and 20%, respectively. In conclusion, our study has shown therapeutic efficacy of PvdQ acylase as a quorum quenching agent during P. aeruginosa infection.
机译:铜绿假单胞菌是与囊性纤维化相关的肺部感染的主要病原体。群体感应(QS)系统调节毒力因子的产生,并在成功建立铜绿假单胞菌感染的过程中发挥重要作用。 QS系统的抑制(称为群体猝灭)使细菌无毒,因此可作为开发新型抗生素的替代方法。革兰氏阴性细菌的群体猝灭可以通过防止N-酰基高丝氨酸内酯(AHL)信号分子通过酶促降解而积累来实现。我们先前的工作表明,PvdQ酰基转移酶不可逆地水解AHL信号分子,从而在体外和铜绿假单胞菌感染的秀丽隐杆线虫模型中抑制QS。本研究的目的是评估鼻内滴注的PvdQ酰基转移酶在肺部铜绿假单胞菌感染的小鼠模型中的治疗效果。首先,我们通过体内成像研究评估了鼻内施用荧光染料标记的PvdQ(PvdQ-VT)在肺部感染不同阶段的小鼠中的沉积模式。鼻内滴注后,可以在所有肺叶中追踪到PvdQ-VT,其中在细菌感染后0小时沉积了42±7.5%的输送剂量,在细菌感染后72小时沉积了34±5.2%。然后,我们在致死性铜绿假单胞菌肺部感染过程中用PvdQ处理了小鼠,结果肺部细菌负荷降低了5倍,感染动物的存活期延长了,而PBS-的中位存活时间为42小时,而中位数为57 hin治疗组。在亚致死性铜绿假单胞菌肺部感染中,PvdQ治疗导致较少的肺部炎症以及细菌感染后24小时的CXCL2和TNF-α水平分别降低15%和20%。总之,我们的研究表明铜绿假单胞菌感染期间PvdQ酰基转移酶作为定额猝灭剂的治疗效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号